查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541620

2024-2032 年按产品（连网感测器、整合连网设备）、最终用户（医院和医疗保健提供者、家庭护理）、技术（蓝牙、NFC 等）和区域分類的联网给药设备市场报告

Connected Drug Delivery Devices Market Report by Product (Connected Sensors, Integrated Connected Devices), End User (Hospitals and Healthcare Providers, Homecare), Technology (Bluetooth, NFC, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球连网给药设备市场规模达到8.644亿美元。对远端监控和远距医疗的需求、人口老化以及慢性阻塞性肺病（COPD）发病率的增加是推动市场成长的一些关键因素。

连网给药设备市场分析：

主要市场驱动因素：改善病患治疗结果和医疗管理成本的需求不断增加。

主要市场趋势：对家庭照护的日益偏好和慢性病数量的增加提供了有利的市场前景。

地理趋势：由于强大的医疗基础设施和持续的技术创新，北美占据了最大的市场份额。

竞争格局：连网给药设备产业的一些主要市场参与者包括 Aderium Ltd.、BioCorp Production、Cohero Health Inc. (AptarGroup Inc.)、Elcam Medical ACS。有限公司、芬达航空有限公司z oo、Merck KGaA、Phillips Medisize (Molex LLC)、Propeller Health (Resmed Inc.)、Teva Pharmaceutical Industries Ltd. 和 West Pharmaceutical Services Inc. 等。

挑战与机会：虽然市场面临病患治疗资料安全问题等挑战，这会影响市场，但在维护电子健康记录（EHR）方面也遇到了机会。

连网给药设备市场趋势：

人口老化加剧

随着人们年龄的增长，他们患糖尿病、高血压和心血管疾病等持续疾病的风险更大。连接的药物传输设备透过确保精确的药物剂量和监测，在有效处理这些情况方面发挥重要作用。此外，这些设备可以透过提醒、追踪剂量以及将记录机械地传输给医疗保健公司来简化这些治疗方案。连接的药物传输设备可以远端追踪药物依从性和健康参数。这使得医疗保健公司能够及早干预问题，从而支持就地老化。世界卫生组织（WHO）网站上发表的一篇文章显示，到2050年，全球60岁以上的人口预计将增加一倍，达到近21亿。

慢性阻塞性肺病（COPD）盛行率上升

根据世界卫生组织（WHO）网站2023年更新的内容，近90%的70岁以下慢性阻塞性肺病死亡发生在低收入和中等收入国家。慢性阻塞性肺病患者需要精确、可控制的药物输送，其中包括支气管扩张剂和皮质类固醇。连接的药物传输设备可确保正确剂量和及时给药，这对于有效应对慢性阻塞性肺病症状至关重要。此外，连接的设备可以监控吸入策略并向患者提供即时回馈。这使得慢性阻塞性肺病患者能够优化他们的吸入方法，确保他们从药物中获得最大的益处。与此一致的是，慢性阻塞性肺病是一种革命性的疾病，需要持续监测症状和肺功能。连接设备可远端监测慢性阻塞性肺病患者的健康状况，包括肺部特征测试和症状监测，有助于及早发现病情加重并及时调整治疗计划。

蓬勃发展的远距医疗产业

IMARC Group的报告显示，2023年全球远距医疗市场规模将达到747亿美元。连接的药物输送设备透过允许即时追踪患者的药物依从性、治疗反应和健康状态来补充远距医疗。这种持续监测有利于糖尿病、高血压和呼吸道疾病等疾病的持续疾病管理。此外，连网的药物传输设备可以与远距医疗结构相结合，使医疗保健公司能够远端改变药物剂量、提供客製化的护理计划并监测人员的发展。这种整合透过直接使用来自患者家中的可操作统计数据和见解，提高了远距医疗咨询的效能和有效性。

连网给药设备市场细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、最终用户和技术对市场进行了分类。

按产品划分：

连接的传感器

连接的吸入器感测器

可连接的注射感测器

整合连接设备

连接的吸入设备

连接的注射设备

连网感测器占据大部分市场份额

该报告根据产品提供了详细的市场细分和分析。这包括连接的感测器（连接的吸入器感测器、可连接的注射感测器）和整合的连接设备（连接的吸入设备、连接的注射设备）。根据该报告，连接感测器代表了最大的部分。

连接的传感器可实现即时追踪和事实收集，使医疗保健提供者能够远端追踪患者对药物治疗方案和生理反应的依从性。这种程度的连结透过保证及时干预和随后的修改来提高治疗品质。此外，连接的传感器增强了患者对治疗过程的高效和有效的参与和参与。随着个人化医疗的需求不断增长，配备感测器的连网给药设备可以提供有关患者健康指标的宝贵见解，提高治疗效率并降低与不依从或次优治疗併发症相关的医疗成本。

按最终用户划分：

医院和医疗保健提供者

居家护理

医院和医疗保健提供者占据行业最大份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院和医疗保健提供者以及家庭护理。报告称，医院和医疗保健提供者占据了最大的市场份额。

医院和医疗保健提供者优先考虑病患照护和安全，透过实现精确药物管理和监控的连网设备可以显着增强病患照护和安全。连接的药物传输设备提供有关患者依从性、剂量准确性和治疗有效性的即时资料，从而改善临床结果并减少错误。此外，由于工作效率和资源利用率提高，医疗保健提供者对数位健康解决方案的使用正在增加。智慧型设备与电子病历和其他医院软体和平台配合使用，使它们能够无缝共享资料并提高医院的生产力。

按技术划分：

蓝牙

近场通讯

其他技术

蓝牙代表了领先的细分市场

该报告基于该技术对市场进行了详细的细分和分析。这包括蓝牙、NFC 和其他技术。根据该报告，蓝牙是最大的细分市场。

支援蓝牙的小工具可以更轻鬆地与智慧型手机和平板电脑集成，使患者能够透过用户友好的介面和行动应用程式有效地控制自己的健康状况。蓝牙连接的舒适性和可靠性有助于连接药物输送设备的增加，因为医疗保健供应商正在寻求利用虚拟健身解决方案来提高患者参与度和治疗依从性。除此之外，透过将蓝牙连接整合到药物输送设备中，主要参与者可以提供更强大的功能，例如远端监控、事实系列以及与医疗保健运营商和患者的即时口头交流。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的连网给药设备市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。该报告称，北美是连网给药设备最大的区域市场。

根据医疗保险和医疗补助服务中心网站 2023 年更新的内容，2022 年美国医疗保健支出成长 4.1%，达到 4.5 兆美元，即人均 13,493 美元。医疗保健支出的增加反映出人们更加重视透过创新技术改善患者的治疗结果并降低整体医疗保健成本。北美拥有大量製药公司和医疗设备製造商，它们大力投资连网给药设备的研发 (R&D) 活动。这些公司正在利用物联网 (IoT) 和数位连接的进步来开发创新设备，以增强药物依从性、患者监测和整体治疗结果。此外，该地区有利的报销政策和支持性监管框架也有助于该细分市场的快速成长。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。连网药物输送设备产业的一些主要市场参与者包括 Aderium Ltd.、BioCorp Production、Cohero Health Inc. (AptarGroup Inc.)、Elcam Medical ACS。有限公司、芬达航空有限公司z oo、Merck KGaA、Phillips Medisize (Molex LLC)、Propeller Health (Resmed Inc.)、Teva Pharmaceutical Industries Ltd. 与 West Pharmaceutical Services Inc.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

主要参与者不断改进感测器技术、连接解决方案和行动健康应用程序，以增强连网药物输送设备的功能、可靠性和用户体验。他们还将连网给药设备与数位健康平台和电子病历 (EMR) 整合，以促进无缝资料交换、即时监控和个人化医疗介入。此外，许多公司正在开发用户友好的介面、行动应用程式和教育资源，以提高患者的参与度、治疗方案的依从性以及慢性病的自我管理。他们也正在开发支援个人化医疗方法的连网药物输送设备，例如基于即时资料和患者特定健康资讯的剂量调整。例如，2023年，领先的科技公司默克与BenevolentAI和Exscientia合作，加强人工智慧驱动的药物发现。

连网给药设备市场新闻：

2024 年 5 月 24 日：呼吸电子健康、远端监控和资料管理解决方案领域的领导者 Aderium Limited 宣布，阿斯特捷利康已选择其 Hailie(R) Smartinhaler(R) 平台进行临床试验。该合约为期三年，价值 110 万美元。

2023 年 6 月 6 日：诺和诺德以 1.54 亿欧元收购医疗设备製造商 Biocorp。

本报告回答的关键问题：

  • 迄今为止，全球连网给药设备市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 基于产品的市场区隔是什么？
  • 连网给药设备市场中哪种产品最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 连网给药设备市场中哪一个是最具吸引力的最终用户？
  • 基于技术的市场区隔是什么？
  • 联网给药设备市场中哪一项技术最具吸引力？
  • 市场按地区划分是怎样的？
  • 连网给药设备市场中哪个区域最具吸引力？
  • 市场竞争结构如何？
  • 全球连网给药设备市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球连网给药设备市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 基于产品的市场区隔是什么？
  • 连网给药设备市场中哪种产品最具吸引力？
  • 基于最终用户的市场区隔是什么？
  • 连网给药设备市场中哪一个是最具吸引力的最终用户？
  • 基于技术的市场区隔是什么？
  • 联网给药设备市场中哪一项技术最具吸引力？
  • 市场按地区划分是怎样的？
  • 连网给药设备市场中哪个区域最具吸引力？
  • 市场竞争结构如何？
  • 全球连网给药设备市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球连网给药设备市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 连接的传感器
    • 市场趋势
    • 关键环节
      • 连接的吸入器感测器
      • 可连接的注射感测器
    • 市场预测
  • 整合连接设备
    • 市场趋势
    • 关键环节
      • 连接的吸入设备
      • 连接的注射设备
    • 市场预测

第 7 章：市场区隔：按最终用户

  • 医院和医疗保健提供者
    • 市场趋势
    • 市场预测
  • 居家护理
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 蓝牙
    • 市场趋势
    • 市场预测
  • 近场通讯
    • 市场趋势
    • 市场预测
  • 其他技术
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Adherium Limited
    • BioCorp Production
    • Cohero Health Inc. (AptarGroup Inc.)
    • Elcam Medical ACS. Ltd
    • Findair Sp. z oo
    • Merck KGaA
    • Phillips Medisize (Molex LLC)
    • Propeller Health (Resmed Inc.)
    • Teva Pharmaceutical Industries Ltd.
    • West Pharmaceutical Services Inc.
Product Code: SR112024A3738

The global connected drug delivery devices market size reached US$ 864.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032. The demand for remote monitoring and telemedicine, rising aging population, and increasing occurrence of chronic obstructive pulmonary disease (COPD) are some of the key factors strengthening the growth of the market.

Connected Drug Delivery Devices Market Analysis:

Major Market Drivers: There is a rise in demand for improved patient treatment outcomes and cost of medical management.

Key Market Trends: The growing preferences for home-based care and increasing number of chronic diseases are offering a favorable market outlook.

Geographical Trends: North America holds the largest segment because of strong healthcare infrastructure and ongoing innovations in technology.

Competitive Landscape: Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc., among many others.

Challenges and Opportunities: While the market faces challenges like concerns about patient treatments data security, which impacts the market, it also encounters opportunities in maintaining electronic health records (EHR).

Connected Drug Delivery Devices Market Trends:

Growing aging population

As people are aging, they are encountering greater risk of continual ailments like diabetes, high blood pressure, and cardiovascular diseases. Connected drug delivery devices play an important role in handling those situations effectively by ensuring precise medicinal drug dosing and monitoring. Moreover, these devices can simplify those regimens through reminders, tracking dosages, and transmitting records mechanically to healthcare companies. Connected drug delivery devices allow remote tracking of medicine adherence and fitness parameters. This allows healthcare companies to intervene the issues early, thus supporting aging in place. An article published on the website of the World Health Organization (WHO) shows that individuals aged over 60 are expected to double by 2050, reaching nearly 2.1 billion worldwide.

Rising prevalence of chronic obstructive pulmonary disease (COPD)

As per the content updated in 2023 on the website of the World Health Organization (WHO), nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD patients require precise and managed delivery of medicinal drugs which include bronchodilators and corticosteroids. Connected drug delivery devices ensure correct dosing and timely administration, which is vital for coping with COPD signs effectively. In addition, connected devices can monitor inhalation strategies and provide feedback to patients in actual-time. This allows COPD sufferers optimize their inhalation approach, making sure that they obtain the maximum benefits from their medicines. In line with this, COPD is a revolutionary disease that requires continuous monitoring of symptoms and lung function. Connected devices permit for remote monitoring of COPD patients' fitness fame, consisting of lung feature tests and symptom monitoring, facilitating early detection of exacerbations and timely adjustments to treatment plans.

Thriving telemedicine sector

The IMARC Group's report shows that the global telemedicine market reached US$ 74.7 Billion in 2023. Telemedicine platforms facilitate remote consultations between healthcare providers and patients. Connected drug delivery devices supplement telemedicine by allowing actual-time tracking of patients' medication adherence, treatment response, and fitness status. This ongoing monitoring is beneficial for continual sickness management in conditions like diabetes, high blood pressure, and respiratory illnesses. Additionally, connected drug delivery devices can be incorporated with telehealth structures, permitting healthcare companies to remotely alter medicine dosages, provide customized care plans, and monitor person development. This integration improves the performance and effectiveness of telemedicine consultations by using actionable statistics and insights directly from the patient's home.

Connected Drug Delivery Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, end user, and technology.

Breakup by Product:

Connected Sensors

Connected Inhaler Sensors

Connectable Injection Sensors

Integrated Connected Devices

Connected Inhalation Devices

Connected Injection Devices

Connected sensors accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes connected sensors (connected inhaler sensors, connectable injection sensors) and integrated connected devices (connected inhalation devices, connected injection devices). According to the report, connected sensors represent the largest segment.

Connected sensors enable real-time tracking and facts collection, permitting healthcare providers to remotely track patient adherence to medicinal drug regimens and physiological responses. This level of connectivity improves the quality of treatment by guaranteeing timely interventions and subsequent modification. In addition, connected sensors enhance efficient and effective patient engagement and involvement in their treatment processes. As the demand for personalized medicine is growing, connected drug delivery devices equipped with sensors provide valuable insights into patient health metrics, improving treatment efficiency and reducing healthcare costs associated with complications from non-adherence or suboptimal therapy.

Breakup by End User:

Hospitals and Healthcare Providers

Homecare

Hospitals and healthcare providers hold the largest share of the industry

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and healthcare providers and homecare. According to the report, hospitals and healthcare providers account for the largest market share.

Hospitals and healthcare providers prioritize patient care and safety, which are significantly enhanced by connected devices that enable precise medication administration and monitoring. Connected drug delivery devices offer real-time data on patient adherence, dosage accuracy, and treatment effectiveness, thereby improving clinical outcomes and reducing errors. Furthermore, the use of digital health solutions by the healthcare providers is rising because of better efficiency of work and utilization of resources. Smart devices work with EHRs and other hospital software and platforms, allowing them to share data seamlessly and improve the productivity of the hospital.

Breakup by Technology:

Bluetooth

NFC

Other Technologies

Bluetooth represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes Bluetooth, NFC, and other technologies. According to the report, Bluetooth represents the largest segment.

Bluetooth-enabled gadgets facilitate easier integration with smartphones and tablets, empowering patients to control their health effectively via user-pleasant interfaces and mobile apps. The comfort and reliability of Bluetooth connectivity is assisting the increase of connected drug delivery devices, as healthcare vendors are looking to leverage virtual fitness solutions for higher patient engagement and treatment adherence. Besides this, by means of integrating Bluetooth connectivity into drug delivery devices, key players can provide greater functionalities like remote monitoring, facts series, and real-time verbal exchange with healthcare carriers and patients.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest connected drug delivery devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for connected drug delivery devices.

As per the content updated in 2023 on the website of Centers for Medicare & Medicaid Services, U.S. health care spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. The increasing healthcare expenditure reflects a greater emphasis on improving patient outcomes and reducing overall healthcare costs through innovative technologies. North America has a strong presence of pharmaceutical companies and medical device manufacturers that are investing heavily in research and development (R&D) activities of connected drug delivery devices. These companies are leveraging advancements in Internet of Things (IoT) and digital connectivity to develop innovative devices that enhance medication adherence, patient monitoring, and overall treatment outcomes. Furthermore, favorable reimbursement policies and supportive regulatory frameworks in the region contribute to the rapid growth of this market segment.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players continuously improving sensor technology, connectivity solutions, and mobile health applications to enhance the functionality, reliability, and user experience of connected drug delivery devices. They are also integrating connected drug delivery devices with digital health platforms and electronic medical records (EMRs) to facilitate seamless data exchange, real-time monitoring, and personalized healthcare interventions. Moreover, many companies are developing user-friendly interfaces, mobile apps, and educational resources to enhance patient engagement, adherence to treatment regimens, and self-management of chronic conditions. They are also developing connected drug delivery devices that support personalized medicine approaches, such as dose adjustments based on real-time data and patient-specific health information. For instance, in 2023, Merck, a leading science and technology company collaborated with BenevolentAI and Exscientia to strengthen AI-driven drug discovery.

Connected Drug Delivery Devices Market News:

May 24, 2024: Adherium Limited, a leader in respiratory eHealth, remote monitoring and data management solutions, announced that AstraZeneca has selected its Hailie(R) Smartinhaler(R) platform for a clinical trial. This contract is valued at $1.1M over the course of three years.

June 6, 2023: Novo Nordisk acquired medical device manufacturer Biocorp for €154 million.

Key Questions Answered in This Report:

  • How has the global connected drug delivery devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the connected drug delivery devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the connected drug delivery devices market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the connected drug delivery devices market?
  • What is the breakup of the market based on the region?
  • Which is the most attractive region in the connected drug delivery devices market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global connected drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Connected Drug Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Connected Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Connected Inhaler Sensors
      • 6.1.2.2 Connectable Injection Sensors
    • 6.1.3 Market Forecast
  • 6.2 Integrated Connected Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Connected Inhalation Devices
      • 6.2.2.2 Connected Injection Devices
    • 6.2.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Healthcare Providers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Homecare
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Bluetooth
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 NFC
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Other Technologies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BioCorp Production
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Cohero Health Inc. (AptarGroup Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Elcam Medical ACS. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Findair Sp. z o. o.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Phillips Medisize (Molex LLC)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Propeller Health (Resmed Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 West Pharmaceutical Services Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
  • Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
  • Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
  • Table 7: Global: Connected Drug Delivery Devices Market: Key Players